Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

Cigall Kadoch wins $250,000 Blavatnik National Award

Cigall Kadoch was named the laureate of the Blavatnik National Awards for Young Scientists in the field of life sciences for her work in cancer biology.
September 20, 2024
Vol.50 No.35
Tumors are able to form with no DNA mutations, fly study shows

Tumors are able to form with no DNA mutations, fly study shows

Tumors are able to form without any DNA mutations, according to a recent proof-of-principle study performed in flies. Epigenetic changes alone—even temporary alterations—induced permanent cancer cell fate. 
September 13, 2024
Vol.50 No.34
By Jacquelyn Cobb
In Brief

Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor

Laurie H. GlimcherBenjamin Levine EbertLaurie H. Glimcher will step down as Dana-Farber Cancer Institute president and CEO on Oct. 1. 
September 06, 2024
Vol.50 No.33
In Brief

Pasi Jänne receives 2024 Bonnie J. Addario Lectureship Award

Pasi A. Jänne received the GO2 for Lung Cancer’s 2024 Bonnie J. Addario Lectureship Award.  
August 02, 2024
Vol.50 No.31
In Brief

Nobel Laureate William Kaelin receives Fox Chases’s Stanley P. Reimann Honor Award

Jonathan Chernoff and William G. KaelinWilliam G. Kaelin Jr., physician, scientist, and Nobel laureate, was recognized at Fox Chase Cancer Center with the Stanley P. Reimann Honor Award, the center’s highest distinction. 
April 05, 2024
Vol.50 No.14
Florez Laboratory at Dana-Farber launches International Pregnancy and Lung Cancer Registry
Trials & Tribulations

Florez Laboratory at Dana-Farber launches International Pregnancy and Lung Cancer Registry

For many women, a confirmation of pregnancy tends to evoke numerous emotions: excitement, shock, nervousness, joy, gratitude, and sometimes, even surprise. It is a moment dreamed, prayed, and planned for—but not for all.
February 09, 2024
Vol.50 No.06
By Narjust Florez, Lauren Keil, Rebekah Kaufman and Oyepeju Abioye-Akintola
Impact factor mania and publish-or-perish may have contributed to Dana-Farber retractions, experts say

Impact factor mania and publish-or-perish may have contributed to Dana-Farber retractions, experts say
Learning from past errors (and misconduct) in cancer research

More than a decade ago, Glenn Begley and Lee Ellis published a paper with astounding findings: of 53 “landmark” studies, only six, or 11%, were reproducible, even with the same reagents and the same protocols—and even, sometimes, in the same laboratory—as the original study.
February 02, 2024
Vol.50 No.05
By Jacquelyn Cobb
Dana-Farber to retract six papers, correct 31, over “image discrepancies” in papers co-authored by top leaders

Dana-Farber to retract six papers, correct 31, over “image discrepancies” in papers co-authored by top leaders

Over 50 research papers that list top leaders of Dana-Farber Cancer Institute among authors are implicated in an investigation of allegations of data manipulation. 
January 26, 2024
Vol.50 No.04
By Jacquelyn Cobb
Dana-Farber’s bold split from the Brigham is a culmination of Boston oncology’s complicated history
News Analysis

Dana-Farber’s bold split from the Brigham is a culmination of Boston oncology’s complicated history

It’s a divorce everyone has an opinion on.
December 08, 2023
Vol.49 No.45
By Jacquelyn Cobb
In Brief

Mark Agnel Frederick Dawson, Cigall Kadoch, Michelle Monje receive MSK’s 2023 Paul Marks Prize

Mark Agnel Frederick DawsonCigall KadochMichelle MonjeMemorial Sloan Kettering Cancer Center has named three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research. 
November 17, 2023
Vol.49 No.43

Posts navigation

Previous1234Next

Trending Stories

  • NIH Director Jay Bhattacharya launches a podcast
  • As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention
  • Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures
  • “Forward funding” NIH budget plan would make competing for grants much harder
  • Optimizing dosing of expensive and toxic oncology drugs: Making America healthier
  • The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
    In a time of uncertainty, “react to the knowns, not the fear”

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account